

Newsroom
Press Releases
- Cellumen Finds Increased Predictivity for Human DILI Through Rat Hepatocyte Panel (PDF) 5 Nov 2009
- Cellumen Enters Second Phase of Safety Assessment Testing for EPA ToxCast Program (PDF) 21 Jul 2009
- Cellumen Launches Rat Cardiomyocyte Early Safety Assessment Panel, Signs Contract with International Biotech Company (PDF) 8 Jul 2009
- Cellumen to Present at Bio-IT World Conference & Expo '09 (PDF) 22 Apr 2009
- Cellumen and Alzheimer's Drug Discovery Foundation Announce New Novel Alzheimer's Screening Tool (PDF) 2 Apr 2009
- Cellumen Appoints Dr. Jack A. Reynolds to Board of Directors (PDF) 26 Mar 2009
- Cellumen to Present at Society of Toxicology Annual Meeting (PDF) 9 Mar 2009
- Cellumen Promotes Patricia Johnston to Chief Scientific Officer (PDF) 10 Feb 2009
- Cellumen and Drug Safety Excecutive Council Announce Findings from In Vitro Discovery Toxicology Webinar (PDF) 28 Jan 2009
- Cellumen Expands Discovery Toxicology Services with Cardiac Hypertrophy Panel (PDF) 17 Dec 2008
- Cellumen’s 2008 Collaborations Validate New Approach to Improve Drug Safety and Development
(PDF) 14 Oct 2008
- Cellumen Partners with Alzheimer's Drug Discovery Foundation to Develop New Assays for Early Treatment of Alzheimer
(PDF) 30 Sep 2008
- Cellumen Selected as Signature Partner of Drug Safety Executive Council (PDF) 23 Sep 2008
- Cellumen and Mitsubishi Tanabe Pharma Corp. Collaborate in Discovery Toxicology (PDF) 16 Jul 2008
-
Cellumen Spins Off Personalized Medicine Unit as Cernostics Pathology, Inc.
(PDF) 16 Jul 2008
- Cellumen Collaborates with the NCTR of the FDA to Apply Cellular Systems Biology to Predictive Toxicology (PDF) 30 Jun 2008
- Cellumen Collaborates with Mayo Clinic on Patient Stratification (PDF) 1 Oct 2007
- Safeguard Scientifics Leads Series B Financing for Cellumen, Inc. (PDF) 10 Jul 2007
- Cellumen Uses its Cellular Technology to Profile Toxins for the EPA (PDF) 9 Apr 2007
- Leroy Hood, M.D., Ph.D. Joins Cellumen Scientific Advisory Board (PDF) 13 Nov 2006
- Cellumen, Inc., the Cellular Systems Biology Company, announces that Dr. Rosemary Mazanet has joined the Board of Directors (PDF) 21 Aug 2006
- Cellumen, Inc. and CHDI, Inc. Announce an Agreement to Create a Systems Cell Biology Profile of Huntington Disease (PDF) 23 Feb 2006
- Chemicon International and Cellumen Announce an R&D Agreement to Commercialize a Systems Cell Biology Approach to Cyototxicity Profiling in Drug Discovery 7 Feb 2006
- Cellumen and RheoGene Sign Licensing and Collaboration Agreement (PDF) 26 July 2005
- Former Director of Lead Generation at Eli Lilly Joins Cellumen (PDF) 27 June 2005
- PA Early Stage Makes Series A Investment in Cellumen (PDF) 20 June 2005